LUNDBECK PHARMACEUTICALS ITALY SPA

LUNDBECK PHARMACEUTICALS ITALY SPA (Italy) holds 8 active US FDA Type II Drug Master Files and 4 inactive and has DMF or CEP filings on record for 12 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “LUNDBECK PHARMACEUTICALS ITALY SPA: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/lundbeck-pharmaceuticals-italy-spa

Overview

LUNDBECK PHARMACEUTICALS ITALY SPA is an active pharmaceutical ingredient (API) supplier with 8 active FDA Type II Drug Master Files, covering ARGATROBAN; CLOMIPRAMINE HYDROCHLORIDE; DAPSONE; DESIPRAMINE HYDROCHLORIDE; DIAZOXIDE; IMIPRAMINE PAMOATE.

Core services & business areas

API ManufacturingPharmaceutical Manufacturing

Active ingredients with DMF or CEP filings

Substances for which LUNDBECK PHARMACEUTICALS ITALY SPA holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

LUNDBECK PHARMACEUTICALS ITALY SPA holds 8 active (12 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • IMIPRAMINE PAMOATEActive2008-10-15
  • ARGATROBANActive2008-01-30
  • DAPSONEActive2000-09-29
  • CLOMIPRAMINE HYDROCHLORIDEActive1990-11-19
  • DIAZOXIDEActive1987-06-22
  • TRIMIPRAMINE MALEATEActive1985-04-22
  • METOCLOPRAMIDE HCL MONOHYDRATEActive1983-03-26
  • DESIPRAMINE HYDROCHLORIDEActive1978-10-04
  • ETHOTOINInactive2012-04-10
  • MELPERONE HYDROCHLORIDEInactive2007-07-27
  • ALFUZOSIN HYDROCHLORIDEInactive2007-05-15
  • IMIPRAMINE HYDROCHLORIDEInactive1972-04-05

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LUNDBECK PHARMACEUTICALS ITALY SPA in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this LUNDBECK PHARMACEUTICALS ITALY SPA?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.